Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Riedl

Showing results (81-90 of 196) with videos related to

Pageof 20
Sort By:
Leukemia & Lymphoma|December 3, 2016
High coincidence of chronic lymphocytic leukemia and myeloproliferative neoplasms: detection bias or a clue to a common pathophysiological path?Claire van de Ree-Pellikaan, Lina van der Straten, Jurgen A Riedl, et al.
Allergy and Asthma Proceedings|May 13, 2021
Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needsMarc A Riedl, Timothy J Craig, Aleena Banerji, et al.
Journal of Inorganic Biochemistry|October 4, 2021
Water-soluble trithiolato-bridged dinuclear ruthenium(II) and osmium(II) arene complexes with bisphosphonate functionalized ligands as anticancer organometallicsChristoph A Riedl, Alexander Rosner, Sophia Harringer, et al.
Allergy and Asthma Proceedings|December 22, 2020
Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapiesDouglas T Johnston, H Henry Li, Timothy J Craig, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 13, 2018
Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I StudiesPaula J Busse, Henriette Farkas, Aleena Banerji, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label studyMarc A Riedl, Robyn J Levy, Daniel Suez, et al.
Allergy and Asthma Proceedings|March 15, 2013
Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant womenJames W Baker, Timothy J Craig, Marc A Riedl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2016
Emergency Department Management of Hereditary Angioedema Attacks: Patient PerspectivesIris M Otani, Sandra C Christiansen, Paula Busse, et al.
Dalton Transactions (Cambridge, England : 2003)|March 10, 2018
N- and S-donor leaving groups in triazole-based ruthena(ii)cycles: potent anticancer activity, selective activation, and mode of action studiesChristoph A Riedl, Michaela Hejl, Matthias H M Klose, et al.
American Journal of Rhinology & Allergy|November 27, 2013
Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedemaMarc A Riedl, William R Lumry, H Henry Li, et al.
Pageof 20

Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
Leukemia & Lymphoma|December 3, 2016
High coincidence of chronic lymphocytic leukemia and myeloproliferative neoplasms: detection bias or a clue to a common pathophysiological path?Claire van de Ree-Pellikaan, Lina van der Straten, Jurgen A Riedl, et al.
Allergy and Asthma Proceedings|May 13, 2021
Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needsMarc A Riedl, Timothy J Craig, Aleena Banerji, et al.
Journal of Inorganic Biochemistry|October 4, 2021
Water-soluble trithiolato-bridged dinuclear ruthenium(II) and osmium(II) arene complexes with bisphosphonate functionalized ligands as anticancer organometallicsChristoph A Riedl, Alexander Rosner, Sophia Harringer, et al.
Allergy and Asthma Proceedings|December 22, 2020
Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapiesDouglas T Johnston, H Henry Li, Timothy J Craig, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 13, 2018
Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I StudiesPaula J Busse, Henriette Farkas, Aleena Banerji, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label studyMarc A Riedl, Robyn J Levy, Daniel Suez, et al.
Allergy and Asthma Proceedings|March 15, 2013
Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant womenJames W Baker, Timothy J Craig, Marc A Riedl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2016
Emergency Department Management of Hereditary Angioedema Attacks: Patient PerspectivesIris M Otani, Sandra C Christiansen, Paula Busse, et al.
Dalton Transactions (Cambridge, England : 2003)|March 10, 2018
N- and S-donor leaving groups in triazole-based ruthena(ii)cycles: potent anticancer activity, selective activation, and mode of action studiesChristoph A Riedl, Michaela Hejl, Matthias H M Klose, et al.
American Journal of Rhinology & Allergy|November 27, 2013
Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedemaMarc A Riedl, William R Lumry, H Henry Li, et al.
Pageof 20